Melissa McGinley
Family · West Palm Bch, FLNPI 1386997047
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,345 of the $4,013 with a category attached, or 83.3%. 20 manufacturers reported payments, led by Novartis at 32.2% of the total. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $25.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Medtronic$1K
- Heartflow, Inc.$242
- Pfizer$185
- E.r. Squibb & Sons, L.L.C.$182
- Merck$164
- plus $814 from 14 others
What the payments were for
- Travel & lodging$62416%
- Food & beverage$3,34583%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 64 | $1,292 |
| Medtronic | 14 | $1,135 |
| Heartflow, Inc. | 6 | $242 |
| Pfizer | 9 | $185 |
| E.r. Squibb & Sons, L.L.C. | 8 | $182 |
| Merck | 10 | $164 |
| Boston Scientific | 8 | $160 |
| Johnson & Johnson | 8 | $135 |
| Boehringer Ingelheim | 5 | $107 |
| AstraZeneca | 6 | $106 |
| Amgen | 5 | $79 |
| Kowa Pharmaceuticals America, Inc. | 3 | $53 |
| Novo Nordisk | 2 | $51 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reveal LINQ$140
- LEQVIO$132
- LINQ II$114
How this compares
$4,013 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $44,259 |
| EntrestoSacubitril/Valsartan | 31 | $38,870 |
| Nebivolol Hcl | 12 | $767 |
| Ranolazine ErRanolazine | 13 | $739 |
| Telmisartan | 12 | $510 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $453 |
| Metoprolol Succinate | 36 | $439 |
| Valsartan | 18 | $401 |
| Carvedilol | 41 | $357 |
| Losartan Potassium | 29 | $290 |
| Rosuvastatin Calcium | 12 | $243 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 23 | $232 |
| Clonidine Hcl | 15 | $211 |
| Atorvastatin Calcium | 14 | $123 |
| Furosemide | 20 | $74 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $185 | $44,25944 claims |
| NovartisEntresto | $1,292 | $38,87031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.
Other family in West Palm Bch
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.